Changes Induced by Early HABIT-ILE in Pre-school Children With Uni- and Bilateral Cerebral Palsy (EarlyHABIT-ILE)

May 24, 2022 updated by: Yannick Bleyenheuft, Université Catholique de Louvain

Functional, Neuroplastic and Biomechanical Changes Induced by Early Hand and Arm Bimanual Intensive Therapy Including Lower Extremities (HABIT-ILE) in Pre-school Children With Uni- and Bilateral Cerebral Palsy

Studying in two randomized controlled trials (RCT) the changes induced by early HABIT-ILE in functional, neuroplastic and biomechanical assessment in children with unilateral and bilateral CP.

Study Overview

Status

Active, not recruiting

Conditions

Detailed Description

This study aims to evaluate the effect of two weeks of early Hand-arm Bimanual Intensive Therapy Including Lower Extremities (HABIT-ILE) on bimanual performance in pre-school children with unilateral cerebral palsy (CP) and on gross motor function in those with bilateral CP, compared with two weeks of usual motor activity including usual rehabilitation (control group). We will assess further changes in unilateral performance tests, daily life activities questionnaires and executive function tests. Neuroplastic changes will be assessed using brain imaging (magnetic resonance imaging, MRI) and biomechanical changes will be assessed by using optoelectronic motion capture system with electromyography (EMG), to determine the effect of HABIT-ILE on movement pattern and quality.

Study Type

Interventional

Enrollment (Anticipated)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Brussels, Belgium, 1200
        • Institute of Neuroscience, Université catholique de Louvain
      • Brest, France
        • Fondation ILDYS - Site de Ty Yann
    • Toscana
      • Marina Di Pisa-Tirrenia-Calambrone, Toscana, Italy, 56128
        • IRCCS Fondazione Stella Maris

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

4 months to 3 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • children with unilateral or bilateral cerebral palsy (spastic or dyskinetic)
  • age 1 to 4 years inclusive (corrected age if preterm birth)
  • ability to follow instructions and complete testing according to the age.

Exclusion Criteria:

  • active seizure
  • programmed botulinum toxin or orthopedic surgery in the 6 months previous to the intervention, during intervention period or 3months after the intervention time
  • severe visual impairments
  • severe cognitive impairments
  • contraindications to perform MRI assessments (Metal implants, etc.)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: HABIT-ILE
Early HABIT-ILE (Hand and arm bimanual intensive therapy including lower extremities) will be applied over 2 weeks.
Early Hand and arm bimanual intensive therapy including lower extremities
Active Comparator: Usual Care
A two weeks period of usual customary care
Usual customary care

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change on Gross Motor Function (GMFM-66)
Time Frame: pre-camp, two weeks post-camp, 3 months follow-up.
Developed to assess the changes in gross motor function of children with cerebral palsy (scored in percentage), observed over time or after intervention for the second randomized controlled trial (RCT2)
pre-camp, two weeks post-camp, 3 months follow-up.
Change on Manual Ability (Assisting Hand Assessment (AHA))
Time Frame: pre-camp, two weeks post-camp, 3 months follow-up
Developed to observe the efficacy of the assisting hand use, in children with unilateral cerebral palsy (scored in percentage), during bimanual activities for the first randomized controlled trial (RCT1)
pre-camp, two weeks post-camp, 3 months follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Melbourne 2 Assessment (MA2)
Time Frame: pre-camp, two weeks post-camp, 3 months follow-up
assess the unilateral performance of the upper extremities, quantifying the dexterity, fluency, accuracy and range of movement during several tasks of reaching and manipulation
pre-camp, two weeks post-camp, 3 months follow-up
Inhibitory control task
Time Frame: pre-camp, two weeks post-camp, 3 months follow-up
Measures the inhibition of a motor answer. It's assessed by asking the child not to reach for a toy previously showed to play with. The maximum waiting time is 30 seconds.
pre-camp, two weeks post-camp, 3 months follow-up
Working memory task
Time Frame: pre-camp, two weeks post-camp, 3 months follow-up
Measures the capacity to retain visual information in use, in a short period of time. It's assessed by hiding a toy in front of the child and asking him/her to find it from 4 possibilities.
pre-camp, two weeks post-camp, 3 months follow-up
Visuo-spatial attention assessment
Time Frame: pre-camp, two weeks post-camp, 3 months follow-up
Through different simple tasks, measures the visual field, the visuo-motor coordination, the orientation of attention in the space and the eye pursuit.
pre-camp, two weeks post-camp, 3 months follow-up
Semmes-Weinstein monofilaments
Time Frame: pre-camp, two weeks post-camp, 3 months follow-up
Evaluates the pressure threshold or the response to a touching sensation of the filament. It is quantified using a numerical grading ranging from high pression/clear touching sensation to a slight pression/slight touching sensation.
pre-camp, two weeks post-camp, 3 months follow-up
Pressure Threshold
Time Frame: pre-camp, two weeks post-camp, 3 months follow-up
The superior pressure threshold will be determined at the moment of any visible change in the child's reaction to the pression made by the algometer.
pre-camp, two weeks post-camp, 3 months follow-up
Activlim-CP questionnaire
Time Frame: pre-camp, two weeks post-camp, 3 months follow-up
This parent's filled questionnaire measures a patient's ability to perform daily activities requiring the use of the upper and/or the lower extremities through 43 items specific to patients with cerebral palsy. It ranges from - 7 to +7 logits (higher score means better performance).
pre-camp, two weeks post-camp, 3 months follow-up
Pediatric Evaluation of Disability Inventory questionnaire (PEDI)
Time Frame: pre-camp, two weeks post-camp, 3 months follow-up
This parent's filled questionnaire measures the performance of the child in the daily life activities and movement domains, focusing on the capacity of upper extremities and lower extremities during this activities. It ranges from 0 to 100% (higher score means better performance).
pre-camp, two weeks post-camp, 3 months follow-up
Young children's participation and environment measure (YC-PEM)
Time Frame: pre-camp, two weeks post-camp, 3 months follow-up
Based in different children's activities, this parent's filled questionnaire evaluates the level of participation and the quality of the environment in which these activities take place. For each type of activity, caregivers assess 3 dimensions of the child's participation: frequency (8-point scale; 0-7), level of involvement (5-point scale; 1-5), caregiver's percent desire for change (2-points level (y/n) transformed in percentage; 0-100) and perceived impact of environmental support (3-point scale transformed in percentage; 0-100). A software calculates the total score with a maximum of 212 (higher score means better performance).
pre-camp, two weeks post-camp, 3 months follow-up
Measure of Processes of Care (MPOC-20)
Time Frame: pre-camp, two weeks post-camp, 3 months follow-up

Assesses the parents' perceptions of the care they and their children receive from children's rehabilitation treatment centres. Using a 8-point response scale, parents answer to 20 questions, indicating to what extent they have experienced the events or the situations described. A score of 7 means that they have experienced this aspect to a very great extent, or most of the time. A score of 1 means that they have not experienced this aspect at all. A score of 0 means that the question does not apply to them.

There is no total score. However, because the statements are positively worded, higher total scores indicates that needs of the parents are being met to a great extent.

pre-camp, two weeks post-camp, 3 months follow-up
Canadian Occupational Performance Measure (COPM)
Time Frame: pre-camp, two weeks post-camp, 3 months follow-up
This is an interview-setting designed to capture a patient's self-perception of performance and satisfaction of it in everyday activities, observed over time. During the interview, parents set up 5 activities considered difficult in daily life. These are then assessed, in a 1 to 10 scale, regarding the child's self-perception of performance and satisfaction of it. The total score is the average of the scores for perception and satisfaction separately (score from 1 to 10; higher score means better performance/satisfaction)
pre-camp, two weeks post-camp, 3 months follow-up
3D T1-weighted structural imaging (T1)
Time Frame: pre-camp, 3 months follow-up
This sequence allows to measure changes in gray matter (cortical thickness)
pre-camp, 3 months follow-up
Changes on the Fractional Anisotropy (Diffusion tensor imaging (DTI))
Time Frame: pre-camp, 3 months follow-up
This sequence allows to measure changes in the fractional anisotropy (FA) on the white matter tracts. FA is a scalar value (no unit) between zero and one that describes the degree of anisotropy of white matter water molecules.
pre-camp, 3 months follow-up
Changes on the Mean Diffusivity (Diffusion tensor imaging (DTI))
Time Frame: pre-camp, 3 months follow-up
This sequence allows to measure the mean changes in the diffusivity (MD). MD is a scalar value (no unit) between zero and one that describes the degree of molecular diffusion.
pre-camp, 3 months follow-up
Changes on resting state functional connectivity (RS)
Time Frame: pre-camp, 3 months follow-up
Resting-state functional magnetic resonane imaging (rs-fMRI) evaluates the regional interactions that occur during the resting or task-negative state. The magnitud of the brain activation during rs-fMRI will be assessed
pre-camp, 3 months follow-up
Changes on spatial parameters of the gait (Kinematics assessments)
Time Frame: pre-camp, 3 months follow-up
Through a 3D motion system, we measure the stride length (meters), step length (meters) and step width (meters).
pre-camp, 3 months follow-up
Changes on temporal parameters of the gait (Cycle time)
Time Frame: pre-camp, 3 months follow-up
Through a 3D motion system, we measure cycle of gait time (seconds).
pre-camp, 3 months follow-up
Changes on temporal parameters of the gait (Stance time)
Time Frame: pre-camp, 3 months follow-up
Through a 3D motion system, we measure the stance time (percentage of total gait cycle).
pre-camp, 3 months follow-up
Changes on temporal parameters of the gait (Swing time)
Time Frame: pre-camp, 3 months follow-up
Through a 3D motion system, we measure the swing time (percentage of total gait cycle).
pre-camp, 3 months follow-up
Changes on temporal parameters of the gait (Stride)
Time Frame: pre-camp, 3 months follow-up
Through a 3D motion system, we measure the gait cadence (stride per minute).
pre-camp, 3 months follow-up
Changes on temporal parameters of the gait (Velocity)
Time Frame: pre-camp, 3 months follow-up
Through a 3D motion system, we measure the gait velocity (meter/second)
pre-camp, 3 months follow-up
Changes on temporal parameters of the gait (Acceleration)
Time Frame: pre-camp, 3 months follow-up
Through a 3D motion system, we measure the gait acceleration (meters/second^2)
pre-camp, 3 months follow-up
Changes on spatial parameters of the upper extremity (Straightness)
Time Frame: pre-camp, 3 months follow-up
Through a 3D motion system, we measure the straightness (percentage of upper extremity trajectory during a reaching task).
pre-camp, 3 months follow-up
Changes on spatial parameters of the upper extremity (Smoothness)
Time Frame: pre-camp, 3 months follow-up
Through a 3D motion system, we measure the smoothness (variability of the movement during a reaching task)
pre-camp, 3 months follow-up
Changes on temporal parameters of the upper extremity (Kinematics assessments)
Time Frame: pre-camp, 3 months follow-up
Through a 3D motion system, we measure the time from onset to end of the task (seconds). the task consist in a reaching task.
pre-camp, 3 months follow-up
Quantification of physical activity
Time Frame: 5 hours during 5 consecutive days
With a movement sensor on each wrist, the percentage of total time spent in movement (i.e. crawling, walking and running) is measured. Calculated in terms of the changes in the acceleration (m/s^2). These measurements will be performed during therapy in 5 consecutive days for the HABIT-ILE group and during a regular week for the Usual Care group.
5 hours during 5 consecutive days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Yannick Bleyenheuft, Pr, MSL-IN Lab, Institute of Neuroscience, Université catholique de Louvain

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 27, 2018

Primary Completion (Actual)

December 31, 2021

Study Completion (Anticipated)

June 30, 2022

Study Registration Dates

First Submitted

November 20, 2018

First Submitted That Met QC Criteria

July 11, 2019

First Posted (Actual)

July 16, 2019

Study Record Updates

Last Update Posted (Actual)

May 25, 2022

Last Update Submitted That Met QC Criteria

May 24, 2022

Last Verified

May 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cerebral Palsy

Clinical Trials on HABIT-ILE

3
Subscribe